Where Injected GLP-1 Therapies Still Lead Weekly injections such as Wegovy and Mounjaro remain ahead in: Higher average long-term weight-loss percentages More established long-term safety data Real-world evidence across large patient populations Because injections have been studied for over a decade, they currently hold the strongest clinical outcomes in obesity care
Many patients use them successfully for ongoing weight management and diabetes control
Rashmi Roy, one of the nations highest-volume thyroid surgeons, for an insightful conversation on thyroid cancer risk, diagnosis, and treatment
[5] Kredit to Kourtney Kardashian on Choosing Supresa
The United States does not have a coherent framework for managing the costs and distribution of breakthrough medications that address common chronic conditions
You dont want to get a prescription and walk awaythats not going to work in the long term. About half of patients who start a GLP-1 medication stop within a year, he notes, often because of side effects, cost, or lack of follow-up
